Akebia Therapeutics Inc
NASDAQ:AKBA
Akebia Therapeutics Inc
NASDAQ:AKBA
Price:
0.984
USD
4.83%
Market Closed
Market Cap:
$264m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Akebia Therapeutics Inc
NASDAQ:AKBA
|
US |
|
K
|
KeyMed Biosciences Inc
HKEX:2162
|
CN |
|
N
|
Nexstar Media Group Inc
F:NXZ
|
US |
|
Ad Pepper Media International NV
XETRA:APM
|
DE |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
CL |
|
Panthera Resources PLC
LSE:PAT
|
UK |
|
Element Fleet Management Corp
TSX:EFN
|
CA |
|
S
|
Suez SA
F:SZ1
|
FR |
|
Azerion Group NV
AEX:AZRN
|
NL |
|
Bit Digital Inc
NASDAQ:BTBT
|
US |
Multiples-Based Value
The Multiples-Based Value for Akebia Therapeutics Inc (AKBA) under the Base Case is hidden
USD.
Compared with the current market price of 0.984 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AKBA Multiples-Based Value
LOCKED
